Yes I know totally what you mean, but at the same time it’s a...

Yes I know totally what you mean, but at the same time it’s a well written coverage providing some of the most detailed interpretation of information. What part of the report do disagree with? Do you use more accurate assumptions or calculations than what is included in that detailed report to form your own thesis on the valuation? And if so, it would be helpful for the rest of us to know what those are?

It’s a piece of information Canacord Genuity which are global, needs to hang their hat on too. The assumed NdPr cost is about right in that report.

Lets say if Canacord over estimated the valuation by 50-100% to build a relationship with Vital for capital raising etc, then that would put the valuation $0.55-0.75 range, is still representing significant upside for what the current share price should be.